0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Irbesartan Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13H7971
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Irbesartan Market Insights and Forecast to 2028
BUY CHAPTERS

Global Irbesartan Market Research Report 2025

Code: QYRE-Auto-13H7971
Report
July 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Irbesartan Market

The global market for Irbesartan was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy. It can also be used as part of a combination product with hydrochlorothiazide for patients not well controlled or not expected to be well controlled on monotherapy.
North American market for Irbesartan is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Irbesartan is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Irbesartan include Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Irbesartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irbesartan.
The Irbesartan market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Irbesartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irbesartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Irbesartan Market Report

Report Metric Details
Report Name Irbesartan Market
Segment by Type
  • Combination Drugs
  • Prescribed Drugs
Segment by Application
  • Hyperlipidemia
  • High Blood Pressure
  • Heart Failure
  • Kidney Disease
  • Fibrous Fibrillation
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, Verdant Life Sciences, Angita Pharma, Auro Pharma, Avanstra, Zhuhai Rundu Pharma, Xiansheng Pharmaceutical, CTTQ, Tianjin Huairen Pharmaceutical, Jiangsu Wangao Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Ainuo Pharmaceutical, Yuanhe Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Irbesartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Irbesartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Irbesartan Market report?

Ans: The main players in the Irbesartan Market are Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, Verdant Life Sciences, Angita Pharma, Auro Pharma, Avanstra, Zhuhai Rundu Pharma, Xiansheng Pharmaceutical, CTTQ, Tianjin Huairen Pharmaceutical, Jiangsu Wangao Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Ainuo Pharmaceutical, Yuanhe Pharmaceutical

What are the Application segmentation covered in the Irbesartan Market report?

Ans: The Applications covered in the Irbesartan Market report are Hyperlipidemia, High Blood Pressure, Heart Failure, Kidney Disease, Fibrous Fibrillation, Other

What are the Type segmentation covered in the Irbesartan Market report?

Ans: The Types covered in the Irbesartan Market report are Combination Drugs, Prescribed Drugs

1 Irbesartan Market Overview
1.1 Product Definition
1.2 Irbesartan by Type
1.2.1 Global Irbesartan Market Value Comparison by Type (2024 VS 2031)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Irbesartan by Application
1.3.1 Global Irbesartan Market Value by Application (2024 VS 2031)
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Global Irbesartan Market Size Estimates and Forecasts
1.4.1 Global Irbesartan Revenue 2020-2031
1.4.2 Global Irbesartan Sales 2020-2031
1.4.3 Global Irbesartan Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Irbesartan Market Competition by Manufacturers
2.1 Global Irbesartan Sales Market Share by Manufacturers (2020-2025)
2.2 Global Irbesartan Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Irbesartan Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Irbesartan, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Irbesartan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Irbesartan, Product Type & Application
2.7 Global Key Manufacturers of Irbesartan, Date of Enter into This Industry
2.8 Global Irbesartan Market Competitive Situation and Trends
2.8.1 Global Irbesartan Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Irbesartan Players Market Share by Revenue
2.8.3 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Irbesartan Market Scenario by Region
3.1 Global Irbesartan Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Irbesartan Sales by Region: 2020-2031
3.2.1 Global Irbesartan Sales by Region: 2020-2025
3.2.2 Global Irbesartan Sales by Region: 2026-2031
3.3 Global Irbesartan Revenue by Region: 2020-2031
3.3.1 Global Irbesartan Revenue by Region: 2020-2025
3.3.2 Global Irbesartan Revenue by Region: 2026-2031
3.4 North America Irbesartan Market Facts & Figures by Country
3.4.1 North America Irbesartan Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Irbesartan Sales by Country (2020-2031)
3.4.3 North America Irbesartan Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Irbesartan Market Facts & Figures by Country
3.5.1 Europe Irbesartan Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Irbesartan Sales by Country (2020-2031)
3.5.3 Europe Irbesartan Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Irbesartan Market Facts & Figures by Region
3.6.1 Asia Pacific Irbesartan Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Irbesartan Sales by Region (2020-2031)
3.6.3 Asia Pacific Irbesartan Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Irbesartan Market Facts & Figures by Country
3.7.1 Latin America Irbesartan Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Irbesartan Sales by Country (2020-2031)
3.7.3 Latin America Irbesartan Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Irbesartan Market Facts & Figures by Country
3.8.1 Middle East and Africa Irbesartan Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Irbesartan Sales by Country (2020-2031)
3.8.3 Middle East and Africa Irbesartan Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Irbesartan Sales by Type (2020-2031)
4.1.1 Global Irbesartan Sales by Type (2020-2025)
4.1.2 Global Irbesartan Sales by Type (2026-2031)
4.1.3 Global Irbesartan Sales Market Share by Type (2020-2031)
4.2 Global Irbesartan Revenue by Type (2020-2031)
4.2.1 Global Irbesartan Revenue by Type (2020-2025)
4.2.2 Global Irbesartan Revenue by Type (2026-2031)
4.2.3 Global Irbesartan Revenue Market Share by Type (2020-2031)
4.3 Global Irbesartan Price by Type (2020-2031)
5 Segment by Application
5.1 Global Irbesartan Sales by Application (2020-2031)
5.1.1 Global Irbesartan Sales by Application (2020-2025)
5.1.2 Global Irbesartan Sales by Application (2026-2031)
5.1.3 Global Irbesartan Sales Market Share by Application (2020-2031)
5.2 Global Irbesartan Revenue by Application (2020-2031)
5.2.1 Global Irbesartan Revenue by Application (2020-2025)
5.2.2 Global Irbesartan Revenue by Application (2026-2031)
5.2.3 Global Irbesartan Revenue Market Share by Application (2020-2031)
5.3 Global Irbesartan Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Company Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Irbesartan Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Irbesartan Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BMS
6.3.1 BMS Company Information
6.3.2 BMS Description and Business Overview
6.3.3 BMS Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BMS Irbesartan Product Portfolio
6.3.5 BMS Recent Developments/Updates
6.4 Sumitomo Dainippon Pharma
6.4.1 Sumitomo Dainippon Pharma Company Information
6.4.2 Sumitomo Dainippon Pharma Description and Business Overview
6.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sumitomo Dainippon Pharma Irbesartan Product Portfolio
6.4.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Irbesartan Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Shionogi
6.6.1 Shionogi Company Information
6.6.2 Shionogi Description and Business Overview
6.6.3 Shionogi Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shionogi Irbesartan Product Portfolio
6.6.5 Shionogi Recent Developments/Updates
6.7 Hanall
6.7.1 Hanall Company Information
6.7.2 Hanall Description and Business Overview
6.7.3 Hanall Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hanall Irbesartan Product Portfolio
6.7.5 Hanall Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Company Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Taj Pharmaceuticals Irbesartan Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Company Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Apotex Irbesartan Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Company Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Medicine Irbesartan Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Verdant Life Sciences
6.11.1 Verdant Life Sciences Company Information
6.11.2 Verdant Life Sciences Description and Business Overview
6.11.3 Verdant Life Sciences Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Verdant Life Sciences Irbesartan Product Portfolio
6.11.5 Verdant Life Sciences Recent Developments/Updates
6.12 Angita Pharma
6.12.1 Angita Pharma Company Information
6.12.2 Angita Pharma Description and Business Overview
6.12.3 Angita Pharma Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Angita Pharma Irbesartan Product Portfolio
6.12.5 Angita Pharma Recent Developments/Updates
6.13 Auro Pharma
6.13.1 Auro Pharma Company Information
6.13.2 Auro Pharma Description and Business Overview
6.13.3 Auro Pharma Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Auro Pharma Irbesartan Product Portfolio
6.13.5 Auro Pharma Recent Developments/Updates
6.14 Avanstra
6.14.1 Avanstra Company Information
6.14.2 Avanstra Description and Business Overview
6.14.3 Avanstra Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Avanstra Irbesartan Product Portfolio
6.14.5 Avanstra Recent Developments/Updates
6.15 Zhuhai Rundu Pharma
6.15.1 Zhuhai Rundu Pharma Company Information
6.15.2 Zhuhai Rundu Pharma Description and Business Overview
6.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zhuhai Rundu Pharma Irbesartan Product Portfolio
6.15.5 Zhuhai Rundu Pharma Recent Developments/Updates
6.16 Xiansheng Pharmaceutical
6.16.1 Xiansheng Pharmaceutical Company Information
6.16.2 Xiansheng Pharmaceutical Description and Business Overview
6.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Xiansheng Pharmaceutical Irbesartan Product Portfolio
6.16.5 Xiansheng Pharmaceutical Recent Developments/Updates
6.17 CTTQ
6.17.1 CTTQ Company Information
6.17.2 CTTQ Description and Business Overview
6.17.3 CTTQ Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.17.4 CTTQ Irbesartan Product Portfolio
6.17.5 CTTQ Recent Developments/Updates
6.18 Tianjin Huairen Pharmaceutical
6.18.1 Tianjin Huairen Pharmaceutical Company Information
6.18.2 Tianjin Huairen Pharmaceutical Description and Business Overview
6.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio
6.18.5 Tianjin Huairen Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Wangao Pharmaceutical
6.19.1 Jiangsu Wangao Pharmaceutical Company Information
6.19.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio
6.19.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.20 Zhejiang Huahai Pharmaceutical
6.20.1 Zhejiang Huahai Pharmaceutical Company Information
6.20.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio
6.20.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.21 Zhejiang Ainuo Pharmaceutical
6.21.1 Zhejiang Ainuo Pharmaceutical Company Information
6.21.2 Zhejiang Ainuo Pharmaceutical Description and Business Overview
6.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio
6.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
6.22 Yuanhe Pharmaceutical
6.22.1 Yuanhe Pharmaceutical Company Information
6.22.2 Yuanhe Pharmaceutical Description and Business Overview
6.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Yuanhe Pharmaceutical Irbesartan Product Portfolio
6.22.5 Yuanhe Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Irbesartan Industry Chain Analysis
7.2 Irbesartan Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Irbesartan Production Mode & Process Analysis
7.4 Irbesartan Sales and Marketing
7.4.1 Irbesartan Sales Channels
7.4.2 Irbesartan Distributors
7.5 Irbesartan Customer Analysis
8 Irbesartan Market Dynamics
8.1 Irbesartan Industry Trends
8.2 Irbesartan Market Drivers
8.3 Irbesartan Market Challenges
8.4 Irbesartan Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Irbesartan Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Irbesartan Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Irbesartan Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Irbesartan Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Irbesartan Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Irbesartan Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Irbesartan Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Irbesartan Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Irbesartan, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Irbesartan, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Irbesartan, Product Type & Application
 Table 12. Global Key Manufacturers of Irbesartan, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Irbesartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irbesartan as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Irbesartan Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Irbesartan Sales by Region (2020-2025) & (KG)
 Table 18. Global Irbesartan Sales Market Share by Region (2020-2025)
 Table 19. Global Irbesartan Sales by Region (2026-2031) & (KG)
 Table 20. Global Irbesartan Sales Market Share by Region (2026-2031)
 Table 21. Global Irbesartan Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Irbesartan Revenue Market Share by Region (2020-2025)
 Table 23. Global Irbesartan Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Irbesartan Revenue Market Share by Region (2026-2031)
 Table 25. North America Irbesartan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Irbesartan Sales by Country (2020-2025) & (KG)
 Table 27. North America Irbesartan Sales by Country (2026-2031) & (KG)
 Table 28. North America Irbesartan Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Irbesartan Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Irbesartan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Irbesartan Sales by Country (2020-2025) & (KG)
 Table 32. Europe Irbesartan Sales by Country (2026-2031) & (KG)
 Table 33. Europe Irbesartan Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Irbesartan Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Irbesartan Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Irbesartan Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Irbesartan Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Irbesartan Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Irbesartan Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Irbesartan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Irbesartan Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Irbesartan Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Irbesartan Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Irbesartan Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Irbesartan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Irbesartan Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Irbesartan Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Irbesartan Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Irbesartan Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Irbesartan Sales (KG) by Type (2020-2025)
 Table 51. Global Irbesartan Sales (KG) by Type (2026-2031)
 Table 52. Global Irbesartan Sales Market Share by Type (2020-2025)
 Table 53. Global Irbesartan Sales Market Share by Type (2026-2031)
 Table 54. Global Irbesartan Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Irbesartan Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Irbesartan Revenue Market Share by Type (2020-2025)
 Table 57. Global Irbesartan Revenue Market Share by Type (2026-2031)
 Table 58. Global Irbesartan Price (US$/G) by Type (2020-2025)
 Table 59. Global Irbesartan Price (US$/G) by Type (2026-2031)
 Table 60. Global Irbesartan Sales (KG) by Application (2020-2025)
 Table 61. Global Irbesartan Sales (KG) by Application (2026-2031)
 Table 62. Global Irbesartan Sales Market Share by Application (2020-2025)
 Table 63. Global Irbesartan Sales Market Share by Application (2026-2031)
 Table 64. Global Irbesartan Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Irbesartan Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Irbesartan Revenue Market Share by Application (2020-2025)
 Table 67. Global Irbesartan Revenue Market Share by Application (2026-2031)
 Table 68. Global Irbesartan Price (US$/G) by Application (2020-2025)
 Table 69. Global Irbesartan Price (US$/G) by Application (2026-2031)
 Table 70. Teva Company Information
 Table 71. Teva Description and Business Overview
 Table 72. Teva Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Teva Irbesartan Product
 Table 74. Teva Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Sanofi Irbesartan Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. BMS Company Information
 Table 81. BMS Description and Business Overview
 Table 82. BMS Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. BMS Irbesartan Product
 Table 84. BMS Recent Developments/Updates
 Table 85. Sumitomo Dainippon Pharma Company Information
 Table 86. Sumitomo Dainippon Pharma Description and Business Overview
 Table 87. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. Sumitomo Dainippon Pharma Irbesartan Product
 Table 89. Sumitomo Dainippon Pharma Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. Novartis Irbesartan Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Shionogi Company Information
 Table 96. Shionogi Description and Business Overview
 Table 97. Shionogi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 98. Shionogi Irbesartan Product
 Table 99. Shionogi Recent Developments/Updates
 Table 100. Hanall Company Information
 Table 101. Hanall Description and Business Overview
 Table 102. Hanall Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 103. Hanall Irbesartan Product
 Table 104. Hanall Recent Developments/Updates
 Table 105. Taj Pharmaceuticals Company Information
 Table 106. Taj Pharmaceuticals Description and Business Overview
 Table 107. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 108. Taj Pharmaceuticals Irbesartan Product
 Table 109. Taj Pharmaceuticals Recent Developments/Updates
 Table 110. Apotex Company Information
 Table 111. Apotex Description and Business Overview
 Table 112. Apotex Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 113. Apotex Irbesartan Product
 Table 114. Apotex Recent Developments/Updates
 Table 115. Jiangsu Hengrui Medicine Company Information
 Table 116. Jiangsu Hengrui Medicine Description and Business Overview
 Table 117. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 118. Jiangsu Hengrui Medicine Irbesartan Product
 Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 120. Verdant Life Sciences Company Information
 Table 121. Verdant Life Sciences Description and Business Overview
 Table 122. Verdant Life Sciences Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 123. Verdant Life Sciences Irbesartan Product
 Table 124. Verdant Life Sciences Recent Developments/Updates
 Table 125. Angita Pharma Company Information
 Table 126. Angita Pharma Description and Business Overview
 Table 127. Angita Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 128. Angita Pharma Irbesartan Product
 Table 129. Angita Pharma Recent Developments/Updates
 Table 130. Auro Pharma Company Information
 Table 131. Auro Pharma Description and Business Overview
 Table 132. Auro Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 133. Auro Pharma Irbesartan Product
 Table 134. Auro Pharma Recent Developments/Updates
 Table 135. Avanstra Company Information
 Table 136. Avanstra Description and Business Overview
 Table 137. Avanstra Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 138. Avanstra Irbesartan Product
 Table 139. Avanstra Recent Developments/Updates
 Table 140. Zhuhai Rundu Pharma Company Information
 Table 141. Zhuhai Rundu Pharma Description and Business Overview
 Table 142. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 143. Zhuhai Rundu Pharma Irbesartan Product
 Table 144. Zhuhai Rundu Pharma Recent Developments/Updates
 Table 145. Xiansheng Pharmaceutical Company Information
 Table 146. Xiansheng Pharmaceutical Description and Business Overview
 Table 147. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 148. Xiansheng Pharmaceutical Irbesartan Product
 Table 149. Xiansheng Pharmaceutical Recent Developments/Updates
 Table 150. CTTQ Company Information
 Table 151. CTTQ Description and Business Overview
 Table 152. CTTQ Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 153. CTTQ Irbesartan Product
 Table 154. CTTQ Recent Developments/Updates
 Table 155. Tianjin Huairen Pharmaceutical Company Information
 Table 156. Tianjin Huairen Pharmaceutical Description and Business Overview
 Table 157. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 158. Tianjin Huairen Pharmaceutical Irbesartan Product
 Table 159. Tianjin Huairen Pharmaceutical Recent Developments/Updates
 Table 160. Jiangsu Wangao Pharmaceutical Company Information
 Table 161. Jiangsu Wangao Pharmaceutical Description and Business Overview
 Table 162. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 163. Jiangsu Wangao Pharmaceutical Irbesartan Product
 Table 164. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
 Table 165. Zhejiang Huahai Pharmaceutical Company Information
 Table 166. Zhejiang Huahai Pharmaceutical Description and Business Overview
 Table 167. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 168. Zhejiang Huahai Pharmaceutical Irbesartan Product
 Table 169. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
 Table 170. Zhejiang Ainuo Pharmaceutical Company Information
 Table 171. Zhejiang Ainuo Pharmaceutical Description and Business Overview
 Table 172. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 173. Zhejiang Ainuo Pharmaceutical Irbesartan Product
 Table 174. Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
 Table 175. Yuanhe Pharmaceutical Company Information
 Table 176. Yuanhe Pharmaceutical Description and Business Overview
 Table 177. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 178. Yuanhe Pharmaceutical Irbesartan Product
 Table 179. Yuanhe Pharmaceutical Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Irbesartan Distributors List
 Table 183. Irbesartan Customers List
 Table 184. Irbesartan Market Trends
 Table 185. Irbesartan Market Drivers
 Table 186. Irbesartan Market Challenges
 Table 187. Irbesartan Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Irbesartan
 Figure 2. Global Irbesartan Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Irbesartan Market Share by Type: 2024 & 2031
 Figure 4. Combination Drugs Product Picture
 Figure 5. Prescribed Drugs Product Picture
 Figure 6. Global Irbesartan Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Irbesartan Market Share by Application: 2024 & 2031
 Figure 8. Hyperlipidemia
 Figure 9. High Blood Pressure
 Figure 10. Heart Failure
 Figure 11. Kidney Disease
 Figure 12. Fibrous Fibrillation
 Figure 13. Other
 Figure 14. Global Irbesartan Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Irbesartan Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Irbesartan Sales (2020-2031) & (KG)
 Figure 17. Global Irbesartan Average Price (US$/G) & (2020-2031)
 Figure 18. Irbesartan Report Years Considered
 Figure 19. Irbesartan Sales Share by Manufacturers in 2024
 Figure 20. Global Irbesartan Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Irbesartan Players: Market Share by Revenue in Irbesartan in 2024
 Figure 22. Irbesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Irbesartan Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Irbesartan Sales Market Share by Country (2020-2031)
 Figure 25. North America Irbesartan Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Irbesartan Sales Market Share by Country (2020-2031)
 Figure 29. Europe Irbesartan Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Irbesartan Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Irbesartan Revenue Market Share by Region (2020-2031)
 Figure 37. China Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Irbesartan Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Irbesartan Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Irbesartan Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Irbesartan Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Irbesartan Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Irbesartan by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Irbesartan by Type (2020-2031)
 Figure 59. Global Irbesartan Price (US$/G) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Irbesartan by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Irbesartan by Application (2020-2031)
 Figure 62. Global Irbesartan Price (US$/G) by Application (2020-2031)
 Figure 63. Irbesartan Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS